Hennessy Advisors Inc’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,500
Closed -$3.89M 308
2021
Q4
$3.89M Sell
22,500
-900
-4% -$137K 0.22% 161
2021
Q3
$3.4M Sell
23,400
-400
-2% -$58.5K 0.2% 169
2021
Q2
$3.14M Buy
23,800
+400
+2% +$52.4K 0.17% 208
2021
Q1
$3M Buy
+23,400
New +$2.88M 0.17% 191

Other funds holding DGX

Hennessy Advisors Inc's DGX Position: Q1 2022 in Review

Hennessy Advisors Inc sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 22,500 shares — an estimated $3.89M sold.

Hennessy Advisors Inc first reported a position in DGX in Q1 2021 and held it in 4 quarters. The position peaked at $3.89M in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Hennessy Advisors Inc reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Hennessy Advisors Inc sold 22,500 Quest Diagnostics shares in Q1 2022, an estimated $3.89M.
  • Hennessy Advisors Inc first reported a position in Quest Diagnostics in Q1 2021 and held it in 4 quarters.
  • Hennessy Advisors Inc's Quest Diagnostics position peaked at $3.89M in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Hennessy Advisors Inc's 13F filing for Q1 2022, filed 12 May 2022.